Google
Trusted Resources: News & Events
Latest announcements and gatherings
Gene-Therapy Company Crispr Drops as FDA Puts Trial on Hold
Crispr Therapeutics AG plunged after the gene-editing company said a planned trial of its treatment to help people with sickle-cell disease was being put on hold by U.S. regulators.
Crispr is developing the therapy with Vertex Pharmaceuticals Inc., and the trial had yet to begin. The companies said in a statement Wednesday that the Food and Drug Administration placed a halt on the experiment until the agency could get more information from the companies.
+myBinderRelated Content
-
Edward J. Benz Jr., MDDr. Benz graduated from Harvard Medical ...
-
Robert H. Broyles, PhDRobert H. Broyles was founder and presid...
-
How This Disease Changes the Shape of Your Cells – Amber M. Yateshttps://www.youtube.com/watch?v=hRnrIpUM...
-
Diving into the genetics of Sickle cell diseaseIn recent years, genetics has become a h...
-
Froedtert Hospital, Sickle Cell ClinicSickle cell disease (SCD) is a genetic d...
-
Associations between environmental factors and hospital admissions for sickle cell diseaseSickle cell disease is an increasing glo...
-
Winthrop-University HospitalNYU Winthrop's pediatric hematologists p...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.